Statement | 17 February 2014 Intellectual property and trade India MSF oral testimony to the United States International Trade Commission public hearing 12 min
Statement | 07 February 2014 Hepatitis C MSF responds to reports on Gilead pricing for hepatitis C drug sofosbuvir in developing countries 2 min
Statement | 31 January 2014 Research and development MSF responds to news of pull out of neglected disease R&D by AstraZeneca 2 min
Statement | 28 January 2014 Intellectual property and trade South Africa MSF intervention at WIPO Standing Committee on the Law of Patents 4 min
Statement | 24 January 2014 Research and development MSF intervention on CEWG R&D financing at WHO 134th Executive Board meeting
Statement | 24 January 2014 Antimicrobial resistance Research and development MSF intervention on antimicrobial resistance at WHO 134th Executive Board meeting
Statement | 23 January 2014 Intellectual property and trade Research and development South Africa MSF intervention on access to medicines at WHO 134th Executive Board meeting
Statement | 23 January 2014 Intellectual property and trade MSF intervention on regulatory systems strengthening at WHO 134th Executive Board meeting
